Table 4.
Biomarkers | AUC | 95% CI | p-Value | Sensitivity | Specificity | Criterion | Correct Classification |
---|---|---|---|---|---|---|---|
sCr | 0.87 | 0.80–0.92 | <0.0001 | 77.3 | 87.4 | >2.6 | 85.0% |
S-C3M | 0.61 | 0.52–0.69 | 0.11 | 59.1 | 65.8 | >11.5 | 64.7% |
U-C3M/Cr | 0.81 | 0.72–0.88 | <0.0001 (vs. sCr p = 0.64) |
81.3 | 71.4 | ≤38.5 | 72.9% |
S-C3C | 0.72 | 0.64–0.79 | <0.001 (vs. sCr p = 0.06) |
54.6 | 83.8 | >11.7 | 78.2% |
U-C3C/Cr | 0.58 | 0.48–0.67 | 0.35 | 50.0 | 73.6 | >14.6 | 70.1% |
S-PRO-C3 | 0.64 | 0.55–0.72 | 0.06 | 54.6 | 76.6 | >11.9 | 72.2% |
U-PRO-C3/Cr | 0.52 | 0.42–0.61 | 0.86 | 25.0 | 86.8 | >7.9 | 77.6% |
ROC criteria: Banff score ci3 (advanced fibrosis) vs. ci0–ci2 (low–moderate fibrosis). AUC, area under the curve; CI, confidence interval.